ArticleInvestigative ophthalmology & visual science2026
Charting the Phenotypic Landscape of FBN1 Variants in Marfan Syndrome With Ectopia Lentis Through Extreme Phenotype Sampling.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Phenotypic heterogeneity is a hallmark of Marfan syndrome (MFS) with ectopia lentis (EL), yet genotype-phenotype correlations for ocular traits remain incompletely understood. This study aimed to identify genomic determinants of extreme ocular phenotypes using a combined phenotype-first and genotype-first analytical strategy. Methods: A two-stage discovery-validation genotype-phenotype association study included 490 patients with MFS with FBN1 variants (246 retrospective and 244 prospective validation). Age-adjusted Z-scores were calculated for axial length (AL) and corneal curvature radius (CCR), whereas central corneal thickness (CCT) and white-to-white distance (WTW) were analyzed using raw measurements. Extreme phenotype sampling identified candidate associations, validated prospectively. A genotype score integrating mutational effect and genomic position was developed. Results: FBN1 genotype was significantly associated with Z-AL, with suggestive exploratory associations for WTW and CCT. Haploinsufficient (HI) variants correlated with higher Z-AL, whereas dominant-negative (DN) variants affecting non-critical residues (Others) were enriched among lower Z-AL individuals. Variants in the TGF-β regulatory region (exons 43-65) further distinguished higher Z-AL individuals from those carrying DN variants affecting critical residues (-Cys + CaB). The genotype score demonstrated a significant positive association with Z-AL (β = 0.724, 95% confidence interval [CI] = 0.371-1.077, P < 0.001), independent of age, sex, and EL severity. Higher scores were also associated with thinner CCT and larger WTW, likely secondary to progressive axial elongation. EL severity showed no significant correlation with genotype. Conclusions: Extreme phenotype sampling with independent validation reveals reproducible genotype-phenotype correlations in the MFS ocular system. The genotype score provides preliminary genotype-guided risk stratification for ocular biometric variability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.